To Evaluate Current Efficacy of Antimalarials Used in Timika, Papua, Indonesia
To Evaluate the Efficacy of Chloroquine and SP for Acute Uncomplicated P. Falciparum and the Efficacy of Chloroquine for Acute Uncomplicated P. Vivax in the Timika Region of Papua, Indonesia.
Sponsor: Menzies School of Health Research
Listed as NCT00157859, this NA trial focuses on Falciparum Malaria and Vivax Malaria and remains completed. Sponsored by Menzies School of Health Research, it has been updated 5 times since 2004, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Aug 2020 — Jan 2021 [monthly]
Completed NA
-
Jan 2017 — Aug 2020 [monthly]
Completed NA
First recorded
Apr 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Menzies School of Health Research
- National Health and Medical Research Council, Australia
- National Institute of Health Research and Development, Ministry of Health Republic of Indonesia
- Wellcome Trust
For direct contact, visit the study record on ClinicalTrials.gov .